NASDAQ:CHFS

CHF Solutions Stock Forecast, Price & News

$6.37

+0.01 (+0.16 %)

(As of 10/29/2020 12:00 AM ET)

Add

Compare

Today's Range

$6.25

Now: $6.37▼

$6.79

50-Day Range

$0.28

MA: $1.48▼

$7.08

52-Week Range

$6.25

Now: $6.37▼

$57.00

Volume450,307 shs

Average Volume266,823 shs

Market Capitalization$15.33 million

P/E RatioN/A

Dividend YieldN/A

Beta1.54

CHF Solutions, Inc., a medical device company, focuses on the provision of solutions for patients suffering from fluid overload. The company's commercial product is the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Its Aquadex FlexFlow system includes a console, and disposable blood set and catheter. The company sells its products to hospitals and clinics through its direct Salesforce in the United States; and through independent specialty distributors primarily in Brazil, Germany, Hong Kong, India, Italy, Singapore, Spain, Thailand, and the United Kingdom. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Beat the Market (BTM) Rank^™

3.5 Analyst's Opinion

Consensus Rating
CHF Solutions has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $20.00, CHF Solutions has a forecasted upside of 214.0% from its current price of $6.37.
Amount of Analyst Coverage
CHF Solutions has received no research coverage in the past 90 days.

2.7 Community Rank

Outperform Votes
CHF Solutions has received 320 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
CHF Solutions has received 280 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
CHF Solutions has received 53.33% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about CHF Solutions and other stocks. Vote “Outperform” if you believe CHFS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CHFS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
CHF Solutions does not currently pay a dividend.
Dividend Growth
CHF Solutions does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CHF Solutions insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.60% of the stock of CHF Solutions is held by insiders.
Percentage Held by Institutions
Only 1.87% of the stock of CHF Solutions is held by institutions.

1.3 Earnings and Valuation

Earnings Growth
Earnings for CHF Solutions are expected to grow in the coming year, from ($9.61) to ($4.50) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of CHF Solutions is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of CHF Solutions is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
CHF Solutions has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.49 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Electromedical equipment

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:CHFS

Previous SymbolNASDAQ:SSH

CUSIPN/A

CIK1506492

Webwww.chf-solutions.com

Phone952-345-4200

Employees55

Debt

Debt-to-Equity RatioN/A

Current Ratio3.52

Quick Ratio2.68

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$5.51 million

Price / Sales2.78

Cash FlowN/A

Price / Cash FlowN/A

Book Value$12.79 per share

Price / Book0.50

Profitability

EPS (Most Recent Fiscal Year)($279.28)

Net Income$-18,110,000.00

Net Margins-285.45%

Return on Equity-295.29%

Return on Assets-191.85%

Miscellaneous

Outstanding Shares2,407,000

Market Cap$15.33 million

Next Earnings Date11/3/2020 (Estimated)

OptionableNot Optionable

$6.37

+0.01 (+0.16 %)

(As of 10/29/2020 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive CHFS News and Ratings via Email

Sign-up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter.

CHF Solutions (NASDAQ:CHFS) Frequently Asked Questions

How has CHF Solutions' stock price been impacted by Coronavirus (COVID-19)?

CHF Solutions' stock was trading at $0.3125 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CHFS shares have increased by 1,938.4% and is now trading at $6.37.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of CHF Solutions?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CHF Solutions in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for CHF Solutions.

When is CHF Solutions' next earnings date?

CHF Solutions is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for CHF Solutions.

How were CHF Solutions' earnings last quarter?

CHF Solutions Inc (NASDAQ:CHFS) released its quarterly earnings data on Tuesday, August, 4th. The company reported ($0.10) EPS for the quarter, topping analysts' consensus estimates of ($0.19) by $0.09. The business had revenue of $1.86 million for the quarter. CHF Solutions had a negative net margin of 285.45% and a negative return on equity of 295.29%.
View CHF Solutions' earnings history.

When did CHF Solutions' stock split? How did CHF Solutions' stock split work?

Shares of CHF Solutions reverse split on the morning of Friday, October 13th 2017. The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 12th 2017. An investor that had 100 shares of CHF Solutions stock prior to the reverse split would have 5 shares after the split.

What price target have analysts set for CHFS?

1 analysts have issued 12-month price objectives for CHF Solutions' stock. Their forecasts range from $20.00 to $20.00. On average, they expect CHF Solutions' stock price to reach $20.00 in the next year. This suggests a possible upside of 214.0% from the stock's current price.
View analysts' price targets for CHF Solutions.

Are investors shorting CHF Solutions?

CHF Solutions saw a increase in short interest in October. As of October 15th, there was short interest totaling 2,510,000 shares, an increase of 63.0% from the September 30th total of 1,540,000 shares. Based on an average trading volume of 349,400 shares, the days-to-cover ratio is currently 7.2 days.
View CHF Solutions' Short Interest.

Who are some of CHF Solutions' key competitors?

Some companies that are related to CHF Solutions include Fc Global Realty (FCRE), IRIDEX (IRIX), ReShape Lifesciences (RSLS), Second Sight Medical Products (EYES), Helius Medical Technologies (HSDT), Helius Medical Technologies (HSDT), ENDRA Life Sciences (NDRA), Precision Optics (PEYE), Digirad (DRAD), Viveve Medical (VIVE), Micron Solutions (MICR), Guided Therapeutics (GTHP), Vaso (VASO), ReShape Lifesciences (RSLSD) and Non-Invasive Monitoring Systems (NIMU).
View all competitors.

What other stocks do shareholders of CHF Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CHF Solutions investors own include Biocept (BIOC), IMMUTEP LTD/S (IMMP), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Zosano Pharma (ZSAN), Avinger (AVGR), Co-Diagnostics (CODX), Ibio (IBIO), Inovio Pharmaceuticals (INO) and Onconova Therapeutics (ONTX).

Who are CHF Solutions' key executives?

CHF Solutions' management team includes the following people:

Mr. John L. Erb, Chairman, CEO & Pres (Age 70)
Ms. Claudia Napal Drayton, Chief Financial Officer (Age 51)
Mr. Vitaliy Epshteyn, Sr. VP of Operations & Engineering (Age 41)
Mr. David Lerner, Sr. VP of Corp. Devel. & Technology
Mr. Thomas P. Lynch, VP, Gen. Counsel, Chief Compliance Officer & Sec. (Age 52)

What is CHF Solutions' stock symbol?

CHF Solutions trades on the NASDAQ under the ticker symbol "CHFS."

Who are CHF Solutions' major shareholders?

CHF Solutions' stock is owned by many different institutional and retail investors. Top institutional investors include Triton Wealth Management PLLC (0.10%).
View institutional ownership trends for CHF Solutions.

Which major investors are buying CHF Solutions stock?

CHFS stock was purchased by a variety of institutional investors in the last quarter, including Triton Wealth Management PLLC.
View insider buying and selling activity for CHF Solutions.

How do I buy shares of CHF Solutions?

Shares of CHFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CHF Solutions' stock price today?

One share of CHFS stock can currently be purchased for approximately $6.37.

How big of a company is CHF Solutions?

CHF Solutions has a market capitalization of $15.33 million and generates $5.51 million in revenue each year. The company earns $-18,110,000.00 in net income (profit) each year or ($279.28) on an earnings per share basis. CHF Solutions employs 55 workers across the globe.

What is CHF Solutions' official website?

The official website for CHF Solutions is www.chf-solutions.com.

How can I contact CHF Solutions?

CHF Solutions' mailing address is 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN, 55344. The company can be reached via phone at 952-345-4200 or via email at [email protected]

This page was last updated on 10/29/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings